Penciclovir — CAS 39809-25-1

Penciclovir is a high-purity antiviral API classified as a purine nucleoside analogue with potent activity against Herpes simplex virus (HSV-1 and HSV-2) and Varicella zoster virus (VZV). Mediocon Inc manufactures GMP-compliant Penciclovir at its Aurangabad, Maharashtra facility. The compound is selectively phosphorylated by viral thymidine kinase and then inhibits viral DNA polymerase, providing targeted antiviral activity with minimal effects on host cells.

• Topical treatment of recurrent herpes labialis (cold sores) caused by HSV-1
• Genital herpes (HSV-2) management in combination formulations
• Varicella zoster virus (VZV) infections
• Antiviral prophylaxis in immunocompromised patients

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support